Entia Biosciences Inc (ERGO)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Entia Biosciences Cash from Operations (TTM): -0.7151M for Dec. 31, 2016
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2016 | -0.7151M |
September 30, 2016 | -0.3346M |
June 30, 2016 | -0.4276M |
March 31, 2016 | -0.6499M |
December 31, 2015 | -0.5366M |
September 30, 2015 | -0.7551M |
June 30, 2015 | -0.7333M |
March 31, 2015 | -0.5744M |
December 31, 2014 | -0.6803M |
September 30, 2014 | -0.6792M |
June 30, 2014 | -0.7097M |
March 31, 2014 | -0.7384M |
December 31, 2013 | -0.7667M |
September 30, 2013 | -0.6346M |
June 30, 2013 | -0.5055M |
Date | Value |
---|---|
March 31, 2013 | -0.3753M |
December 31, 2012 | -0.3146M |
September 30, 2012 | -0.1928M |
June 30, 2012 | -0.2631M |
March 31, 2012 | -0.1871M |
December 31, 2011 | -0.2087M |
September 30, 2011 | -0.3039M |
June 30, 2011 | -0.2178M |
March 31, 2011 | -0.318M |
December 31, 2010 | -0.5229M |
September 30, 2010 | -0.4909M |
June 30, 2010 | -0.7247M |
March 31, 2010 | -0.7115M |
December 31, 2009 | -0.5547M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
FluoroPharma Medical Inc | -0.8801M |
RenovaCare Inc | -4.126M |
Xeno Transplants Corp | -- |
Regenerx Biopharmaceuticals Inc | -0.8237M |
OncoVista Innovative Therapies Inc | -0.2644M |